Abstract
Background and objectives
End stage renal disease (ESRD) patients are exposed to the risk of ionizing radiation during repeated imaging studies. The variability in diagnostic imaging policies and the accompanying radiation doses across various renal units is still unknown. We studied this variability at the centre level and quantified the associated radiation doses at the patient level.
Methods
Fourteen Italian nephrology departments enrolled 739 patients on haemodialysis and 486 kidney transplant patients. The details of the radiological procedures performed over one year were recorded. The effective doses and organ doses of radiation were estimated for each patient using standardized methods to convert exposure parameters into effective and organ doses
Results
Computed tomography (CT) was the major contributor (> 77%) to ionizing radiation exposure. Among the haemodialysis and kidney transplant patients, 15% and 6% were in the high (≥ 20 mSv per year) radiation dose groups, respectively. In haemodialysis patients, the most exposed organs were the liver (16 mSv), the kidney (15 mSv) and the stomach (14 mSv), while the uterus (6.2 mSv), the lung (5.7 mSv) and the liver (5.5 mSv) were the most exposed in kidney transplant patients. The average cumulative effective dose (CED) of ionizing radiation among centres in this study was highly variable both in haemodialysis (from 6.4 to 18.8 mSv per patient-year; p = 0.018) and even more so in kidney transplant (from 0.6 to 13.7 mSv per patient-year; p = 0.002) patients.
Conclusions
Radiation exposure attributable to medical imaging is high in distinct subgroups of haemodialysis and transplant patients. Furthermore, there is high inter-centre variability in radiation exposure, suggesting that nephrology units have substantially different clinical policies for the application of diagnostic imaging studies.
Similar content being viewed by others
References
de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomedas LM, Ansell D et al (2009) Cardiovascular and non-cardiovascular mortality among patients starting dialysis. JAMA 302:1782–1789
Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB et al (1999) Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 354:93–99
Kinsella SM, Coyle JP, Long EB, McWilliams SR, Maher MM, Clarkson MR et al (2010) Maintenance hemodialysis patients have high cumulative radiation exposure. Kidney Int 78:789–793
De Mauri A, Brambilla M, Chiarinotti D, Matheoud R, Carriero A, De Leo M (2011) Estimated Radiation exposure from medical imaging in hemodialysis patients. J Am Soc Nephrol 22:571–578
Nguyen KN, Patel AM, Weng FL (2013) Ionizing radiation exposure among kidney transplant recipients due to medical imaging during the pretransplant evaluation. Clin J Am Soc Nephrol 8:833–839
De Mauri A, Brambilla M, Izzo C, Matheoud R, Chiarinotti D, Carriero A et al (2012) Cumulative radiation dose from medical imaging in kidney transplant patients. Nephrol Dial Transplant 27:3645–4365
Brambilla M, De Mauri A, Lizio D, Matheoud R, De Leo M, Carriero A (2014) Estimated radiation risk of cancer from medical imaging in haemodialysis patients. Nephrol Dial Transplant 29:1680–1686
Mettler FA, Huda W, Yoshizumi TT, Mahesh M (2008) Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology 248:254–263
Compagnone G, Ortolani P, Domenichelli S, Ovi V, Califano G, Dall’Ara G et al (2011) Effective and equivalent organ doses in patients undergoing coronary angiography and percutaneous coronary intervention. Med Phys 38:2168–2175
The 2007 recommendations of the International Commission on Radiological Protection: ICRP publication 103. Ann ICRP 2007
Miglioretti ADL (2009) Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 169:2078–2086
ICRP publication 80 (1998) Radiation dose to patients from radiopharmaceuticals. Addendum 2 to ICRP 53. Also, includes addendum 1 to ICRP publication 72. Ann ICRP 28:1–130
Milliken GA, Johnson DE (2009) Analysis of messy data, volume I: designed experiments. Chapman and Hall/CRC, New York
Fazel R, Krumholtz HM, Wang Y, Ross JS, Chen J, Ting HH, Shah ND, Nasir K, Einstein AJ, Nallamothu BK (2009) Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med 361:849–857
Little MP, Wakeford R, Tawn EJ, Bouffler SD, de Gonzalez BA (2009) Risks associated with low doses and low dose rates of ionizing radiation: why linearity may be (almost) the best we can do. Radiology 251:6–12
Board of Radiation Effects Research Division on Earth and Life Sciences National Research Council of the National Academies (2006) Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. National Academies Press, Washington, DC
Brambilla M, De Mauri A, Leva L, Carriero A, Picano E (2013) Cumulative radiation dose from medical imaging in chronic adult patients. Am J Med 126:480–486
Lee YJ, Chung YE, Lim JS, Kim JH, Kim YJ, Lee HJ et al (2012) Cumulative radiation exposure during follow-up after curative surgery for gastric cancer. Korean J Radiol 13:144–151
Stiles BM, Mirza F, Towe CW, Ho VP, Port JL, Lee PC et al (2011) Cumulative radiation dose from medical imaging procedures in patients undergoing resection for lung cancer. Ann Thorac Surg 92:1170–1178
Martin CJ (2007) Effective dose: how should it be applied to medical exposures. Br J Radiol 80:639–647
Acknowledgements
This work was presented in abstract form at the ERA-EDTA Congress–Wien 2016 and the ECMP Congress–Athens 2016.
MIRA-ESRD study Investigators and participating centres: Emilio Balestra (Ancona), Diego Bellino (Genova), Roberta Benevento (Bologna), Cristina Bregant (Trieste), Paola Bregant (Trieste), Barbara Cannillo (Novara), Giuseppe Casto (Pisa), Doriana Chiarinotti (Novara), Sara Cimolai (Mestre), Giacomo Colussi (Milano), Antonio De Agostini (Brescia), Fausto Declich (Lecco), Maria Grazia Facchini (Bologna), Maria Alessandra Galione (Lecco), Cesare Gavotti (Genova), Ugo Gerini (Trieste), Paola Isoardi (Torino), Cristina Izzo (Novara), Fabrizio Levrero (Genova), Eric Lorenzon (Trieste), Stefano Maffei (Torino), Stefania Maggi (Ancona), Alberto Mari (Ancona), Federico Mattana (Genova), Alberto Menegotto (Milano), Ophelia Meniconi (Pisa), Nicoletta Paruccini (Monza), Luisa Pierotti (Bologna), Federico Pieruzzi (Monza), Giuseppe Pontoriero (Lecco), Adele Postorino (Reggio Calabria), Marco Quaglia (Novara), Osvaldo Rampado (Torino), Andrea Ranghino (Torino), Sonia Reccanello (Mestre), Stefania Sabatino (Udine), Giulia Sangalli (Lecco), Chiara Sottocornola (Pisa), Marina Sutto (Milano), Salvatore Tata (Mestre), Alberto Torresin (Milano), Antonio Traino (Pisa), Annalisa Trianni (Udine), Letizia Zeni (Brescia).
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest and funding statement
The authors have no conflicts of interest and no funding to declare.
Ethical approval
The Institutional Review Board approved the study of each participating centre.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The members of the MIRA-ESRD Study Investigators are mentioned "Acknowledgements" section.
Rights and permissions
About this article
Cite this article
Postorino, M., Lizio, D., De Mauri, A. et al. Radiation dose from medical imaging in end stage renal disease patients: a Nationwide Italian Survey. J Nephrol 34, 791–799 (2021). https://doi.org/10.1007/s40620-020-00911-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40620-020-00911-0